Neurotrophic factor therapy - Prospects and problems

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 4, 2001, Pages 351-355

  Apfel, Stuart C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Brain derived neutrophic factor; Cholinergic neurotrophic factors; Immunoglobulin factor 1 (IGF 1); Nerve growth factor; Neurotrophic factors; Neurotrophin 3

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; PLACEBO; RECOMBINANT CILIARY NEUROTROPHIC FACTOR; RECOMBINANT NERVE GROWTH FACTOR; SOMATOMEDIN C; XALIPRODEN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEVER; HUMAN; INFLAMMATION; INJECTION SITE; LOW BACK PAIN; MOTOR NEURON DISEASE; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; STOMATITIS; WEIGHT REDUCTION;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES;

ANIMALIA;

EID: 0035026831     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.055     Document Type: Article

References (30)

1. Levi-Montalcini R. The nerve growth factor: thirty five years later. EMBO J 1987; 6:1145-54.
2. Cohen S, Levi-Montalcini R, Hamburger V. A nerve growth stimulating factor isolated from sarcomas 37 and 180. Proc Natl Acad Sci USA 1954; 40:1014-8.
3. Ernfors P, Lee KF, Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 1994; 368:147-50.
4. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA, et al. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992; 360:757-9.
5. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350:230-2.
6. Hory-Lee F, Russell M, Lindsay RM, Frank E. Neurotrophin-3 supports the survival of developing muscle sensory neurons in culture. Proc Natl Acad Sci USA 1993; 90:2613-7.
7. Ernfors P, Lee KF, Kucera J, Jaenisch R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994; 77:503-12.
8. Adler R, Landa KB, Manthorpe M, Varon S. Cholinergic neurotrophic factors: intraocular distribution of soluble trophic activity for ciliary neurons. Science 1979; 204:1434-6.
9. Sendtner M, Gotz R, Holtmann B, Thoenen H. Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice. J Neurosci 1997; 17:6999-7006.
10. Kanje M, Skottner A, Sjoberg J, Lundborg G. Insulin like growth factor I (IGF-1) stimulates regeneration of the rat sciatic nerve. Brain Res 1989; 486:396-8.
11. Lewis ME, Neff NT, Contreras PC, Stong DB, Oppenheim RW, Grebow PE, et al. Insulin-like growth factor-1: potential for treatment of motor neuronal disorders. Exp Neurol 1993; 124:73-88.
12. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F, et al. GDNF: a glial cell line-derived neurotrophic factor for mid-brain dopaminergic neurons. Science 1993; 260:1130-2.
13. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994; 266:1062-4.
14. Buj-Bello A, Buchman VI, Horton A, Rosenthal A, Davied AM. GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 1995; 15:821-8.
15. Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med 1988; 318:1306-9.
16. Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, Rask CA . Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology 1998; 51:695-702.
17. McArthur JC, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology 2000; 54:1080-8.
18. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Eng J Med 1998; 338:1174-80.
19. Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmlogy 2000; 107:1347-51.
20. Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy. A randomized controlled trial. J Am Med Assoc 2000; 284:2215-1.
21. Miller RG, Petajan JH, Bryan WW, Armon C, Barohn RJ, Goodpasture JC, et al. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann Neurol 1996; 39:256-60.
22. ALS CNTF Treatment Study Group. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis, Neurology 1996; 46:1244-9.
23. Bradley WG, and The BDNF Trial Group. A phase I/II study of recombinant human brain-derived neurotrophic factor in patients with amyotrophic lateral sclerosis [abstract]. Ann Neurol 1995;:971.
24. The BDNF Study Group (Phase III). A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999; 52:1427-33.
25. Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, et al. Effect of recombinant human insulin-like growth factor-1 on progression of ALS. Neurology 1997; 49:1621-30.
26. Borasio GD, Robberecht W, Leigh PN, Emile J, Guiloff RJ, Jerusalem F, et al. A placebo-controlled trial of insulin-like growth factor-1 in amyotrophic lateral sclerosis. Neurology 1998; 51:583-6.
27. Hefti F, Hartikka J, Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible uses in the treatment of neurodegenerative diseases. Neurobiol Aging 1989; 10:515-33.
28. Fischer W, Wiktorin K, Bjorklund A, Williams LR, Varon S, Gage FH. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987; 329:65-8.
29. 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient [case report]. J Neural Transm 1992; 4:79-95.
30. Eriksdotter-Jonhagen M, Nordberg A, Amberla K, Backman L, Ebendal T, Meyerson B, et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dementia Ger Cognit Disord 1998; 9:246-57.